A comprehensive ranking of drug suppliers during the corona crisis using fuzzy ARAS method

From the production era, every product was distributed using the supply chain and its different parts to reach the final consumer. One of the most important issues in supply chain management is supplier selection, which should be selected optimally to reduce costs; the pharmaceutical industry is no exception to this. In December ۲۰۱۹, after a short period of the outbreak of COVID-۱۹, the issue of medicine and its supply became one of the world's most significant and challenging issues; Therefore, the present study was conducted under the title of identifying evaluation criteria and ranking of drug suppliers in the conditions of the Corona crisis with the approach of fuzzy multi-criteria decision-making methods in Iran for study and research in this field. In the first step of the research, after studying the background of the research and interviewing the experts, ۳۴ measures were set. In the following, ۱۳ criteria were screened by designing and distributing a Delphi questionnaire. In the next step, using the fuzzy DEMATEL Analytic Network Process (DANP) method, the weighting of the criteria was done, the standard of the power of persuasion of company representatives had the highest weight, and the measure of the potential of complementary cooperation had the lowest weight the following criteria were screened using Fuzzy Delphi fuzzy Additive Ratio Assessment (ARAS) to rank the suppliers. This research shows the most effective criteria, the best drug suppliers in the Corona crisis, and their strengths and weaknesses.

کلیدواژه ها:

Supplier selection ، Pharmaceutical industry ، COVID-۱۹ ، Crisis Supply Chain ، Fuzzy Delphi ، Fuzzy additive ratio assessment